auth.
Time
Click Count
Vietnam’s Ministry of Industry and Trade (MOIT) has implemented a new import requirement for reverse osmosis (RO) and ultrafiltration (UF) membrane modules, effective 10 May 2026. Under this regulation, all RO/UF membrane imports must be accompanied by a salt rejection (NaCl rejection) test report issued by a laboratory accredited by the China National Accreditation Service for Conformity Assessment (CNAS), valid within six months of issuance. Failure to provide such documentation will result in customs rejection or detention at Hanoi or Ho Chi Minh City ports — a development with direct implications for membrane exporters, distributors, and water treatment system integrators serving the Vietnamese market.
Made public via MOIT Circular No. 28/2026/TT-BCT, the requirement took effect on 10 May 2026. It mandates that every shipment of RO or UF membrane components imported into Vietnam must include a CNAS-accredited laboratory’s verified salt rejection test report. The report must be no older than six months at the time of customs clearance. This applies uniformly across all points of entry, with enforcement confirmed for Hanoi and Ho Chi Minh City customs authorities.
Direct trading enterprises: Companies exporting RO/UF membranes from China (and potentially other countries where CNAS-recognized labs are used for pre-shipment testing) face new documentation obligations. Since CNAS accreditation is China-specific, non-Chinese exporters may need to coordinate with CNAS-accredited labs — adding lead time and verification steps before shipment.
Raw material procurement enterprises: Firms sourcing membrane elements for local assembly or system integration in Vietnam must now verify upstream suppliers’ ability to supply CNAS-compliant test reports — not just product specifications or manufacturer certificates.
Manufacturing enterprises: Local manufacturers incorporating imported RO/UF membranes into end-use equipment (e.g., residential purifiers, industrial water systems) may experience delays in component acceptance and production scheduling if incoming shipments lack valid reports.
Distribution and channel enterprises: Distributors handling inventory across multiple brands must ensure traceability and document readiness per batch — increasing administrative load and requiring updated internal compliance checks prior to warehouse receipt.
Supply chain service providers: Freight forwarders, customs brokers, and third-party logistics providers supporting membrane imports must now validate report authenticity, issue date, and CNAS lab status as part of pre-clearance review — expanding their scope of documentary due diligence.
Analysis shows that while CNAS accreditation is well established in China, its acceptance for Vietnamese import purposes depends on MOIT’s current list of recognized labs. Enterprises should verify whether their testing lab appears on any MOIT-published reference list — and monitor for potential expansions or revisions to that list.
Observably, the six-month validity period begins at report issuance — not sample collection or test completion. Exporters must align lab testing schedules closely with planned shipment dates to avoid expiry before customs submission. Buffer time of at least 10–14 days is advisable.
From an industry perspective, this rule signals stricter technical verification — but actual enforcement rigor (e.g., sampling frequency, report audit depth) remains subject to customs practice. Early adopters should treat initial shipments as test cases and document clearance outcomes for internal process refinement.
Current best practice involves integrating CNAS report generation into standard operating procedures for export-ready batches — including file naming conventions, bilingual labeling (if required), and digital archiving with metadata (issue date, lab ID, test lot number). Pre-submission validation with local customs brokers is recommended for first-time filers.
This measure is better understood as a procedural tightening rather than a market access restriction. Analysis shows it does not introduce new performance thresholds (e.g., minimum salt rejection %), nor does it ban specific origins or technologies. Rather, it elevates evidentiary standards for a single, critical performance parameter — suggesting Vietnam is strengthening post-market surveillance capacity for water treatment components. Observably, similar requirements have preceded broader conformity assessment frameworks in other ASEAN markets; this may be an early indicator of future alignment with regional technical regulations. Industry stakeholders should therefore view this not as an isolated compliance hurdle, but as a signal of evolving regulatory maturity in Vietnam’s water infrastructure sector.
Conclusion
This regulation marks a formalization of technical documentation expectations for RO/UF membrane imports into Vietnam — shifting emphasis from supplier declarations to third-party verified test evidence. Its immediate impact lies in added coordination, timing, and verification responsibilities across the trade chain. It is more accurately interpreted as a procedural upgrade than a barrier — one that rewards preparedness, traceability, and cross-border lab coordination. For affected businesses, the priority is not policy resistance, but systematic adaptation to a more evidence-based import regime.
Information Sources
Main source: Vietnam Ministry of Industry and Trade (MOIT), Circular No. 28/2026/TT-BCT, effective 10 May 2026.
Note: Ongoing observation is warranted regarding MOIT’s published list of accepted CNAS-accredited laboratories and any subsequent guidance on report format, language, or digital submission protocols.
Recommended News
TIME
auth.
